Howard Federoff is the founder of Aspen Neuroscience. Aspen Neuroscience has raised $77M in total funding. Latest round: Series A.
Dr. Howard Federoff is the Chief Executive Officer of Aspen Neuroscience, a biotech company developing the first autologous neuron replacement therapy for Parkinson's disease. He led the company through a $70 million Series A financing round and was a key figure in its launch following a $6.5 million seed round in 2019.
Full founder directory · Investor directory · Company funding database · Fundraising library